Point72 Hong Kong’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,148
Closed -$24K 1445
2022
Q2
$24K Sell
3,148
-667
-17% -$5.09K ﹤0.01% 1065
2022
Q1
$93K Buy
3,815
+1,804
+90% +$44K ﹤0.01% 687
2021
Q4
$65K Buy
2,011
+668
+50% +$21.6K ﹤0.01% 733
2021
Q3
$60K Buy
1,343
+197
+17% +$8.8K ﹤0.01% 875
2021
Q2
$43K Buy
+1,146
New +$43K ﹤0.01% 945